⌘K

Home/Filings/4/0001415889-21-005472

4//SEC Filing

BRADY ANN 4

Accession 0001415889-21-005472

CIK 0001583107other

View on SEC.gov Company Profile

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 8:26 PM ET

Size

4.8 KB

Accession

0001415889-21-005472

Insider Transaction Report

Form 4

Period: 2021-11-19

Theravance Biopharma, Inc.TBPH

President, TBIL

Transactions

Tax Payment
Ordinary Shares
2021-11-19$8.36/sh−3,169$26,493→ 118,688 total

Footnotes (1)

[F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Documents

1 file

4
form4-11232021_051113.xmlPrimary

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1

filerCIK 0001767974

Filing Metadata

Form type: 4
Filed: Nov 22, 7:00 PM ET
Accepted: Nov 23, 8:26 PM ET
Size: 4.8 KB

View on SEC.gov